Ontology highlight
ABSTRACT:
SUBMITTER: Kim D
PROVIDER: S-EPMC9142968 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature
Pharmaceuticals (Basel, Switzerland) 20220519 5
The US Centers for Disease Control and Prevention (CDC) lists <i>Clostridioides difficile</i> as an urgent bacterial threat. Yet, only two drugs, vancomycin and fidaxomicin, are approved by the FDA for the treatment of <i>C. difficile</i> infections as of this writing, while the global pipeline of new drugs is sparse at best. Thus, there is a clear and urgent need for new antibiotics against that organism. Herein, we disclose that AJ-024, a nitroimidazole derivative of a 26-membered thiopeptide, ...[more]